Sort
30,917 grants matching “tumor microenvironment”
Cancer cell adaptation to metabolic stress
$1,189,982M. Celeste Simon · University Of Pennsylvania · P01 · FY2011 · CA
Biomarker Investigations for Clinical Trials
$1,189,791Kerstin Heselmeyer · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Targeting the MET Pathway in Urothelial Carcinoma
$1,189,328Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Nuclear Structure and Gene Expression
$1,189,273Gary S. Stein · Univ Of Massachusetts Med Sch Worcester · P01 · FY2009 · CA
Dual targeting of tumoral microenvironment and tumoral cells by blocking the IL-33/ST2 pathway
$1,188,901Sophie Paczesny · Indiana University Indianapolis · U01 · FY2018 · CA
Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
$1,188,642Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · P01 · FY2008 · CA
Treg-depleting immunotherapy
$1,188,595Peter David Suzdak · Sonoval Llc · R44 · FY2021 · CA
Cancer cell adaptation to metabolic stress
$1,187,477M. Celeste Simon · University Of Pennsylvania · P01 · FY2012 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$1,185,798Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Modulation of Therapeutic Response
$1,184,062James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2021 · CA
Cellular In vivo Imaging
$1,183,945Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Overhauser Enhanced Magnetic Resonance Imaging (OMRI)
$1,183,002Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$1,183,002Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2012 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2016 · CA
Immuno/Immuno-Gene Therapies for Thoracic Malignancies
$1,182,811Steven Mark Albelda · University Of Pennsylvania · P01 · FY2015 · CA
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
$1,182,020Peter A Jones · University Of Southern California · P30 · FY2009 · CA
Proteogenomic characterization of early and late resistance mechanisms in acute myeloid leukemia
$1,181,536Jeffrey Wallace Tyner · Oregon Health & Science University · U01 · FY2022 · CA
Intracellular In vivo Imaging
$1,181,188Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Tumor Microenvironment Interactions in Brain Tumors
$1,180,000Eric C Holland · Sloan-Kettering Inst Can Research · U54 · FY2006 · CA
Resource for Molecular Imaging Agents in Precision Medicine
$1,179,527Martin G Pomper · Johns Hopkins University · P41 · FY2021 · EB
Development of tumor-targeted PARP inhibitors for the treatment of solid cancers
$1,179,389Vishwas Paralkar · Cybrexa, Inc. · R44 · FY2020 · CA
Pathways that Suppress or Accelerate Premalignant Progression of Squamous Cancer
$1,178,938Stuart H. Yuspa · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Multiscale Mathematical Modeling of Cancer Progression
$1,178,908Vito Quaranta · Vanderbilt University · U54 · FY2014 · CA
Regulatory Crosstalk Between Human Endogenous Retroviruses, HIV, and EBV, in Lymphoma
$1,178,618Douglas F Nixon · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · CA